Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03048162 |
Date of registration:
|
04/02/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
The Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index
|
Scientific title:
|
The Evaluation of the Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index |
Date of first enrolment:
|
February 13, 2017 |
Target sample size:
|
93 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03048162 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Single (Participant).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Turkey
| | | | | | | |
Contacts
|
Name:
|
Seval Ekerer, Dr |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Gaziosmanpasa University |
|
Name:
|
Aynur Sahin, Dr |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Gaziosmanpasa University |
|
Name:
|
Serkan Karaman, Dr |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Gaziosmanpasa University |
|
Name:
|
Tugba Karaman, Dr |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Gaziosmanpasa University |
|
Name:
|
Hakan Tapar, Dr |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Gaziosmanpasa University |
|
Name:
|
Mustafa Suren, Dr |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Gaziosmanpasa University |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- having a fasting period of 8 hours
- quit smoking for 8 hours before the procedure
Exclusion Criteria:
- not to participate in the study
- presence of peripheral vascular disease
- a history of upper extremity surgery
- presence of any kind of psychiatric disease
Age minimum:
18 Years
Age maximum:
45 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Perfusion
|
Intervention(s)
|
Drug: Hydroxyethylstarch
|
Drug: Ringer-Lactate Infusion Solution Bag
|
Drug: sodium chloride
|
Primary Outcome(s)
|
Perfusion index
[Time Frame: six months]
|
Secondary Outcome(s)
|
Heart rate
[Time Frame: six months]
|
Oxygen saturation
[Time Frame: six months]
|
Pulse variability index
[Time Frame: six months]
|
Blood pressure
[Time Frame: six months]
|
Secondary ID(s)
|
OMU KAEK 2016/390
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|